But, before you exit, stage left, for a decade, please enlighten us with your infinite wisdom. Please explain to us why it is that although the need to explore the ways in which endothelial cells provide support, if not control, for hematopoietic processes has been emphasized throughout the scientific community for quite a number of years now, the FDA would say "naaaaaah"?----
Why, would the FDA NOT APPROVE trials for an intelligent cell therapy source? A therapy source that stands to assist in paving the way for revolutionary treatments for many inherited (and some acquired) diseases?----
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.